Maryam Zarghooni
Maryam Zarghooni
Unknown affiliation
Verified email at utoronto.ca
TitleCited byYear
Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor α and poly (ADP-ribose) polymerase as potential …
M Zarghooni, U Bartels, E Lee, P Buczkowicz, A Morrison, A Huang, ...
Journal of clinical oncology 28 (8), 1337-1344, 2010
2652010
Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker
GM Yousef, LG Kyriakopoulou, A Scorilas, S Fracchioli, B Ghiringhello, ...
Cancer research 61 (21), 7811-7818, 2001
1302001
Microfluidic approaches for isolation, detection, and characterization of extracellular vesicles: current status and future directions
S Gholizadeh, MS Draz, M Zarghooni, A Sanati-Nezhad, S Ghavami, ...
Biosensors and Bioelectronics 91, 588-605, 2017
602017
Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer’s disease patients
M Zarghooni, A Soosaipillai, L Grass, A Scorilas, N Mirazimi, ...
Clinical biochemistry 35 (3), 225-231, 2002
602002
New frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targets
P Mokarram, M Albokashy, M Zarghooni, MA Moosavi, Z Sepehri, ...
Autophagy 13 (5), 781-819, 2017
472017
A urora Kinase B Is a Potential Therapeutic Target in Pediatric Diffuse Intrinsic Pontine Glioma
P Buczkowicz, M Zarghooni, U Bartels, A Morrison, KL Misuraca, T Chan, ...
Brain pathology 23 (3), 244-253, 2013
302013
Molecular analysis of cell lines from patients with mucolipidosis II and mucolipidosis III
M Zarghooni, SSR Dittakavi
American Journal of Medical Genetics Part A 149 (12), 2753-2761, 2009
262009
Rosiglitazone, a PPARγ agonist, ameliorates palmitate-induced insulin resistance and apoptosis in skeletal muscle cells.
BS Meshkani R, Sadeghi A, Taheripak G, Zarghooni M, Gerayesh-Nejad S
Cell Biochem Funct 32 (8), 683-91, 2014
202014
Comparison of HCMV IE and EF-1 promoters for the stable expression of β-subunit of hexosaminidase in CHO cell lines
I Sinici, M Zarghooni, MB Tropak, DJ Mahuran, HA Özkara
Biochemical genetics 44 (3-4), 168-175, 2006
152006
An α-subunit loop structure is required for GM2 activator protein binding by β-hexosaminidase A
M Zarghooni, S Bukovac, M Tropak, J Callahan, D Mahuran
Biochemical and biophysical research communications 324 (3), 1048-1052, 2004
142004
Association between Leptin G2548A and leptin receptor Q223R polymorphisms with type 2 diabetes in an iranian population
R Meshkani, A Nasimian, G Taheripak, M Zarghooni, M Rezaei, ...
Clinical laboratory 62 (1-2), 89-96, 2016
22016
Aurora Kinase B Inhibition as a Potential Therapy in Paediatric Glioblastoma Including Diffuse Intrinsic Pontine Glioma
P Buczkowicz, M Zarghooni, U Bartels, A Morrison, E Bouffet, U Tabori, ...
NEURO-ONCOLOGY 13, I6-I6, 2011
2011
OM-10. COMPARISON OF COPY NUMBER AND EXPRESSION PROFILES OF PEDIATRIC HIGH-AND LOW-GRADE BRAINSTEM GLIOMAS TO PEDIATRIC SUPRATENTORIAL HIGH-GRADE ASTROCYTOMAS
P Buczkowicz, U Bartels, A Morrison, M Zarghooni, E Bouffet, C Hawkins
Neuro-oncology 12 (suppl_4), 2010
2010
-Omics and Prognostic Markers
A Ilhan, L Wagner, M Maj, A Woehrer, T Czech, H Heinzl, C Marosi, ...
Neuro-Oncology 12 (suppl_4), iv61-iv68, 2010
2010
GENETIC COMPARISON OF PEDIATRIC DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPG) TO HIGH AND LOW GRADE ASTROCYTOMAS
C Hawkins, P Buczkowicz, U Bartels, U Tabori, I Fried, M Zarghooni, ...
Neuro-oncology 12 (6), 2010
2010
Integrated Analysis of Copy Number Alteration and RNA Expression Profile in Pediatric Diffuse Intrinsic Pontine Glioma (DIPG)
C Hawkins, M Zarghooni, P Buczkowicz, U Bartels, I Fried, U Tabori, ...
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 69 (5), 527-528, 2010
2010
Integrated analysis of copy number alteration and RNA expression profile in pediatric diffuse intrinsic pontine glioma
M Zarghooni, U Bartels, E Bouffet, C Hawkins
Cancer Research 70 (8 Supplement), 1991-1991, 2010
2010
Pediatric diffuse intrinsic pontine gliomas are genetically distinct from high and low grade astrocytomas
B Pawel, U Bartels, A Morrison, M Zarghooni, E Bouffet, C Hawkins
Cancer Research 70 (8 Supplement), 2129-2129, 2010
2010
MOLECULAR ANALYSIS OF CELL LINES FROM PATIENTS WITH MUCOLIPIDOSIS II AND MUCOLIPIDOSIS III: TH06-101
M Zarghooni, S Dittakavi
Journal of Neurochemistry 110, 2009
2009
MUTATIONAL ANALYSIS OF GNPTAB AND GNPTG GENES IN MUCOLIPIDOSIS II AND III AND IN VITRO CORRECTION OF THE CORRESPONDING PHENOTYPES: PSM06-02
M Zarghooni, S Dittakavi
Journal of Neurochemistry 108, 2009
2009
The system can't perform the operation now. Try again later.
Articles 1–20